Genprex, Inc. (GNPX) stock
GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.08−0.13 (-5.88%)
Close on Nov 13, 2026Market cap $1.70MP/E –Yield –
Genprex enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Genprex's enterprise value was -$13.99M on Nov 11, 2026, against $64.30M a year earlier. Over the last 5 years it ranged from -$14.02M to $2.36B, with a median of $130.15M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$13.99M | -137.3% |
| 2025 | Dec 31, 2025 | $37.56M | -62.9% |
| 2024 | Dec 31, 2024 | $101.36M | -64.9% |
| 2023 | Dec 29, 2023 | $289.03M | -80.8% |
| 2022 | Dec 30, 2022 | $1.51B | +12.8% |
| 2021 | Dec 31, 2021 | $1.34B | -62.7% |
| 2020 | Dec 31, 2020 | $3.58B | +3186.9% |
| 2019 | Dec 31, 2019 | $108.99M | -69.3% |
| 2018 | Dec 31, 2018 | $354.47M | – |
See a number that looks wrong?